Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 20Unknown 3Terminated 3Withdrawn 1Recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

CNS 1

Conditions

Lymphoma, Large B-Cell, Diffuse 3Hodgkin Disease 3Lymphoma, Non-Hodgkin 2Lymphoma, Mantle-Cell 2Uveal Melanoma 1Recurrence 1Precursor Cell Lymphoblastic Leukemia-Lymphoma 1Pediatric Brain Tumor 1Pancreatic Neoplasms 1Neoplasm Metastasis 1Melanoma 1Lymphoma, T-Cell 1Lymphoma, Follicular 1Lymphoma 1Glioblastoma 1Burkitt Lymphoma 1Breast Neoplasms 1Brain Neoplasms 1

Interventions

Magnetic Resonance Spectroscopy 23Radiosurgery 21Temozolomide 14Bevacizumab 11pembrolizumab 10Specimen Handling 9Nivolumab 8Radiotherapy 7Ipilimumab 7Magnetic Resonance Imaging 6Cyclophosphamide 5Capecitabine 5Blood Specimen Collection 5encorafenib 4Radiation 4Neuropsychological Tests 4Mental Status and Dementia Tests 4Memantine 4Carboplatin 4fludarabine 3fluciclovine F-18 3binimetinib 3abemaciclib 3Watchful Waiting 3Proton Therapy 3Etoposide 3Dexamethasone 3Adrenal Cortex Hormones 3trastuzumab deruxtecan 2sacituzumab govitecan 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Recruiting × Brain Neoplasms × Carmustine × Clear all
NCT04222062 2026-04-28

A Study Comparing GLIADEL to Stereotactic Radiosurgery in Metastatic Brain Disease

University of Nebraska

Phase 2 Recruiting
100 enrolled
CNS

Brain Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡